ProteVin
Commercial- Indications
- Nutrition
Company intelligence / Profile preview
NextFerm has developed several commercial products based on proprietary non-GMO yeast fermentation technology. These include ProteVin™ (a vegan protein), Astaferm™ (fermented astaxanthin for antioxidant use), NextFreeze™ (yeast product for freeze-thaw resistance in foods), and a biofuel-oriented yeast strain. The company’s focus has been on scaling up manufacturing and commercialization of these products in the global food industry.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NextFerm Technologies.